Filomena De Falco

7PUBLICATIONS
23CO-AUTHORS
Haematological tumoursNanomedicineCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 29, 2026
Rab GTPases drive ligand-independent NOTCH1 activation via altered endocytic trafficking in chronic lymphocytic leukemia.

|Sep 14, 2024
Nanotechnology Advances in the Detection and Treatment of Lymphoid Malignancies.

Francesco Maria Adamo, Filomena De Falco, Erica Dorillo

|Jun 19, 2024
Monitoring Response and Resistance to Treatment in Chronic Lymphocytic Leukemia.

Ilaria Del Giudice, Irene Della Starza, Filomena De Falco

|Jul 29, 2023
Therapeutic Targeting Potential of Novel Silver Nanoparticles Coated with Anti-CD20 Antibody against Chronic Lymphocytic Leukemia.

Francesco Maria Adamo, Estevao Carlos Silva Barcelos, Filomena De Falco

|Jun 10, 2023
Antibody Response to the SARS-CoV-2 Vaccine and COVID-19 Vulnerability during the Omicron Pandemic in Patients with CLL: Two-Year Follow-Up of a Multicenter Study.

Francesca R Mauro, Diana Giannarelli, Clementina M Galluzzo

|Dec 09, 2022
Immune correlates of protection by vaccine against SARS-CoV-2 in patients with chronic lymphocytic leukaemia.

Daniele Sorcini, Filomena De Falco, Marco Gargaro

Pageof 2

Frequent Collaborators

6 joint publications

Paolo Sportoletti

2 joint publications

Mauro Di Ianni

1 joint publications

Beatrice Del Papa

1 joint publications

Stefano Baldoni